Dole plc Reports First Quarter 2023 Financial Results
Highlights for the three months ended March 31, 2023:
-
Announced in January 2023 our agreement to sell our Fresh Vegetables division to Fresh Express, for gross proceeds of approximately
. Following this agreement, the results of this division are reported separately as discontinued operations in our first quarter financial statements$293.0 million -
First quarter Revenue of
, an increase of$2.0 billion 1.0% -
First quarter Adjusted EBITDA1 of
, an increase of$100.4 million 9.3% -
First quarter Adjusted Net Income of
and Adjusted Diluted EPS of$32.3 million $0.34
Financial Highlights - Unaudited
|
|
Three Months Ended |
|||
|
|
March 31, 2023 |
|
March 31, 2022 |
|
|
|
|
|
|
|
|
|
( |
|||
Revenue |
|
1,989 |
|
1,970 |
|
Income from continuing operations2 |
|
35.0 |
|
28.6 |
|
Net Income |
|
20.5 |
|
3.4 |
|
Net Income (Loss) attributable to Dole plc |
|
14.2 |
|
(1.4 |
) |
Diluted EPS from continuing operations |
|
0.30 |
|
0.26 |
|
Diluted EPS |
|
0.15 |
|
(0.01 |
) |
Adjusted EBITDA1 |
|
100.4 |
|
91.9 |
|
Adjusted Net Income1 |
|
32.3 |
|
40.5 |
|
Adjusted Diluted EPS1 |
|
0.34 |
|
0.43 |
|
1 Dole plc reports its financial results in accordance with |
2 Fresh Vegetables results are reported separately as discontinued operations, net of income taxes, in our condensed consolidated statements of operations, its assets and liabilities are separately presented in our condensed consolidated balance sheets, and its cash flows are included within the condensed consolidated cash flows for all periods presented. Unless otherwise noted, our discussion of our results included herein, outlook and all supplementary tables, including non-GAAP financial measures, are presented on a continuing operations basis. |
Commenting on the results, Carl McCann, Executive Chairman, said:
"We are pleased to have started the year strongly and to have delivered Adjusted EBITDA growth in the first quarter.
During the quarter, we announced an agreement to sell our Fresh Vegetables division to Fresh Express. We are continuing to work through the regulatory process for the sale of this business.
We believe the Group is well-positioned for growth and continue to target Adjusted EBITDA of
Group Results - First Quarter
Revenue increased
Adjusted EBITDA increased
Adjusted Net Income decreased
_________________________
3 Like-for-like basis refers to the measure excluding the impact of foreign currency translation movements and acquisitions and divestitures. |
Selected Segmental Financial Information (Unaudited)
|
Three Months Ended |
||||||||||||
|
March 31, 2023 |
|
March 31, 2022 |
||||||||||
|
|
|
|
|
|
|
|
||||||
|
( |
||||||||||||
|
Revenue |
|
Adjusted EBITDA |
|
Revenue |
|
Adjusted EBITDA |
||||||
Fresh Fruit |
$ |
798,910 |
|
|
$ |
69,211 |
|
$ |
749,803 |
|
|
$ |
60,397 |
Diversified Fresh Produce - EMEA |
|
798,100 |
|
|
|
23,406 |
|
|
791,155 |
|
|
|
19,277 |
Diversified Fresh Produce - |
|
422,751 |
|
|
|
7,770 |
|
|
463,692 |
|
|
|
12,209 |
Intersegment |
|
(30,594 |
) |
|
|
— |
|
|
(34,419 |
) |
|
|
— |
Total |
$ |
1,989,167 |
|
|
$ |
100,387 |
|
$ |
1,970,231 |
|
|
$ |
91,883 |
Fresh Fruit
Revenue increased
Adjusted EBITDA increased
Diversified Fresh Produce – EMEA
Revenue increased
Adjusted EBITDA increased
Diversified Fresh Produce –
Revenue decreased
Adjusted EBITDA decreased
Vegetables Transaction
On January 30, 2023, we entered into a Stock Purchase Agreement (the “Agreement”) with Fresh Express Acquisitions LLC (“Fresh Express”), a wholly owned subsidiary of Chiquita Holdings Limited, pursuant to which Fresh Express has agreed to acquire our Fresh Vegetables division for approximately
Cyber Incident
In February of 2023, Dole experienced a cybersecurity incident identified as ransomware. Upon detecting the attack, the Company promptly took steps to investigate and contain the threat, retaining the services of leading third-party cybersecurity experts and working with law enforcement. The incident had a limited impact on our operations overall, however it was disruptive for our Fresh Vegetables and Chilean businesses in particular. Direct costs related to the incident were
Capital Expenditures
Capital expenditures for the three months ended March 31, 2023 were
Net Debt
Net Debt as of March 31, 2023 was
Outlook for Fiscal Year 2023 (forward-looking statement)
The operating environment so far in 2023 continues to bring with it both new opportunities and new challenges. We see signs of improved logistical efficiencies in several areas, which is helping to bring more stability after a period of severe supply chain disruption.
We have also seen some unusual weather events, and as we progress through the second quarter, we are closely monitoring the impact of unprecedented rains this year in
We have continued to see positives for our business, with the strengthening Euro relative to the US Dollar, more stable fuel prices and continued signs of inflation moderating in certain areas. However, we are also seeing headwinds with interest rates remaining high and other unusual currency movements.
Overall, we believe our strong first quarter has put us in an excellent position to deliver on our full year financial targets.
Our business is well-positioned for growth, and while we remain cautious given that the environment we operate in remains dynamic, we continue to expect to deliver Adjusted EBITDA from continuing operations of
The above outlook includes non-GAAP financial measures. Please refer to the appendix of this release for an explanation and reconciliation of our historical non-GAAP financial measures used in this release to comparable GAAP financial measures.
Dividend
On May 17, 2023, the Board of Directors of Dole plc declared a cash dividend for the first quarter of 2023 of
About Dole plc
A global leader in fresh produce, Dole plc produces, markets, and distributes an extensive variety of fresh fruits and vegetables sourced locally and from around the world. Dedicated and passionate in exceeding our customers’ requirements in over 75 countries, our goal is to make the world a healthier and a more sustainable place.
Webcast and Conference Call Information
Dole plc will host a conference call and simultaneous webcast at 08:00 a.m. Eastern Time today to discuss the first quarter 2023 financial results. The webcast can be accessed at www.doleplc.com/investor-relations
The conference call can be accessed live by dialing (646) 307-1963 in the US or +353 (1) 582 2023 in
Forward-looking information
Certain statements made in this press release that are not historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are based on management’s beliefs, assumptions, and expectations of our future economic performance, considering the information currently available to management. These statements are not statements of historical fact. The words “believe,” “may,” “could,” “will,” “should,” “would,” “anticipate,” “estimate,” “expect,” “intend,” “objective,” “seek,” “strive,” “target” or similar words, or the negative of these words, identify forward-looking statements. The inclusion of this forward-looking information should not be regarded as a representation by us or any other person that the future plans, estimates, or expectations contemplated by us will be achieved. Such forward-looking statements are subject to various risks and uncertainties and assumptions relating to our operations, financial results, financial condition, business prospects, growth strategy and liquidity. Accordingly, there are, or will be, important factors that could cause our actual results to differ materially from those indicated in these statements. If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, our actual results may vary materially from what we may have expressed or implied by these forward-looking statements. We caution that you should not place undue reliance on any of our forward-looking statements. Any forward-looking statement speaks only as of the date on which such statement is made, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made except as required by the federal securities laws.
Appendix
Consolidated Statement of Operations - Unaudited
|
Three Months Ended |
||||||
|
March 31, 2023 |
|
March 31, 2022 |
||||
|
|
|
|
||||
|
( |
||||||
Revenues, net |
$ |
1,989,167 |
|
|
$ |
1,970,231 |
|
Cost of sales |
|
(1,810,128 |
) |
|
|
(1,818,436 |
) |
Gross profit |
|
179,039 |
|
|
|
151,795 |
|
Selling, marketing, general and administrative expenses |
|
(120,879 |
) |
|
|
(109,544 |
) |
Gain on disposal of businesses |
|
— |
|
|
|
242 |
|
Gain on asset sales |
|
3,973 |
|
|
|
495 |
|
Operating income |
|
62,133 |
|
|
|
42,988 |
|
Other income, net |
|
1,775 |
|
|
|
2,464 |
|
Interest income |
|
2,309 |
|
|
|
1,584 |
|
Interest expense |
|
(21,712 |
) |
|
|
(11,616 |
) |
Income from continuing operations before income taxes and equity earnings |
|
44,505 |
|
|
|
35,420 |
|
Income tax expense |
|
(10,994 |
) |
|
|
(7,358 |
) |
Equity method earnings |
|
1,478 |
|
|
|
577 |
|
Income from continuing operations |
|
34,989 |
|
|
|
28,639 |
|
Loss from discontinued operations, net of income taxes |
|
(14,506 |
) |
|
|
(25,230 |
) |
Net income |
|
20,483 |
|
|
|
3,409 |
|
Less: Net income attributable to noncontrolling interests |
|
(6,324 |
) |
|
|
(4,803 |
) |
Net income (loss) attributable to Dole plc |
$ |
14,159 |
|
|
$ |
(1,394 |
) |
|
|
|
|||||
Income (loss) per share - basic: |
|
|
|
||||
Continuing operations |
$ |
0.30 |
|
|
$ |
0.26 |
|
Discontinued operations |
|
(0.15 |
) |
|
|
(0.27 |
) |
Net income (loss) per share attributable to Dole plc - basic |
$ |
0.15 |
|
|
$ |
(0.01 |
) |
|
|
|
|
||||
Income (loss) per share - diluted: |
|
|
|
||||
Continuing operations |
$ |
0.30 |
|
|
$ |
0.26 |
|
Discontinued operations |
|
(0.15 |
) |
|
|
(0.27 |
) |
Net income (loss) per share attributable to Dole plc - diluted |
$ |
0.15 |
|
|
$ |
(0.01 |
) |
|
|
|
|
||||
Weighted-average shares: |
|
|
|
||||
Basic |
|
94,899 |
|
|
|
94,878 |
|
Diluted |
|
95,024 |
|
|
|
94,909 |
|
Consolidated Balance Sheets - Unaudited
|
March 31, 2023 |
|
December 31, 2022 |
||||
|
|
|
|
||||
ASSETS |
( |
||||||
Cash and cash equivalents |
$ |
266,200 |
|
|
$ |
228,840 |
|
Short-term investments |
|
5,584 |
|
|
|
5,367 |
|
Trade receivables, net of allowances for credit losses of |
|
634,785 |
|
|
|
610,384 |
|
Grower advance receivables, net of allowances for credit losses of |
|
112,818 |
|
|
|
106,864 |
|
Other receivables, net of allowances for credit losses of |
|
124,292 |
|
|
|
132,947 |
|
Inventories, net of allowances of |
|
405,553 |
|
|
|
394,150 |
|
Prepaid expenses |
|
47,342 |
|
|
|
48,995 |
|
Other current assets |
|
23,688 |
|
|
|
15,034 |
|
Fresh Vegetables current assets held for sale |
|
384,609 |
|
|
|
62,252 |
|
Other assets held for sale |
|
10,784 |
|
|
|
645 |
|
Total current assets |
|
2,015,655 |
|
|
|
1,605,478 |
|
Long-term investments |
|
16,619 |
|
|
|
16,498 |
|
Investments in unconsolidated affiliates |
|
125,377 |
|
|
|
124,234 |
|
Actively marketed property |
|
29,393 |
|
|
|
31,007 |
|
Property, plant and equipment, net of accumulated depreciation of |
|
1,105,179 |
|
|
|
1,116,124 |
|
Operating lease right-of-use assets |
|
317,218 |
|
|
|
293,658 |
|
Goodwill |
|
503,259 |
|
|
|
497,453 |
|
DOLE brand |
|
306,280 |
|
|
|
306,280 |
|
Other intangible assets, net of accumulated amortization of |
|
48,593 |
|
|
|
50,990 |
|
Fresh Vegetables non-current assets held for sale |
|
— |
|
|
|
343,828 |
|
Other assets |
|
132,189 |
|
|
|
142,180 |
|
Deferred tax assets, net |
|
70,080 |
|
|
|
64,112 |
|
Total assets |
$ |
4,669,842 |
|
|
$ |
4,591,842 |
|
LIABILITIES AND EQUITY |
|
|
|
||||
Accounts payable |
$ |
624,045 |
|
|
$ |
640,620 |
|
Income taxes payable |
|
20,624 |
|
|
|
11,558 |
|
Accrued liabilities |
|
387,378 |
|
|
|
381,688 |
|
Bank overdrafts |
|
11,898 |
|
|
|
8,623 |
|
Current portion of long-term debt, net |
|
255,052 |
|
|
|
97,435 |
|
Current maturities of operating leases |
|
61,216 |
|
|
|
57,372 |
|
Payroll and other tax |
|
26,407 |
|
|
|
27,187 |
|
Contingent consideration |
|
603 |
|
|
|
1,791 |
|
Pension and postretirement benefits |
|
17,059 |
|
|
|
17,287 |
|
Fresh Vegetables current liabilities held for sale |
|
311,453 |
|
|
|
199,255 |
|
Dividends payable and other current liabilities |
|
18,357 |
|
|
|
17,698 |
|
Total current liabilities |
|
1,734,092 |
|
|
|
1,460,514 |
|
Long-term debt, net |
|
1,013,984 |
|
|
|
1,127,321 |
|
Operating leases, less current maturities |
|
266,226 |
|
|
|
246,723 |
|
Deferred tax liabilities, net |
|
118,606 |
|
|
|
118,403 |
|
Income taxes payable, less current portion |
|
30,458 |
|
|
|
30,458 |
|
Contingent consideration, less current portion |
|
6,482 |
|
|
|
5,022 |
|
Pension and postretirement benefits, less current portion |
|
118,761 |
|
|
|
124,646 |
|
Fresh Vegetables non-current liabilities held for sale |
|
— |
|
|
|
116,380 |
|
Other long-term liabilities |
|
44,141 |
|
|
|
43,390 |
|
Total liabilities |
$ |
3,332,750 |
|
|
$ |
3,272,857 |
|
|
|
|
|
||||
Redeemable noncontrolling interests |
|
32,964 |
|
|
|
32,311 |
|
Stockholders’ equity: |
|
|
|
||||
Common stock — |
|
949 |
|
|
|
949 |
|
Additional paid-in capital |
|
794,864 |
|
|
|
795,063 |
|
Retained earnings |
|
475,718 |
|
|
|
469,249 |
|
Accumulated other comprehensive loss |
|
(100,911 |
) |
|
|
(104,133 |
) |
Total equity attributable to Dole plc |
|
1,170,620 |
|
|
|
1,161,128 |
|
Equity attributable to noncontrolling interests |
|
133,508 |
|
|
|
125,546 |
|
Total equity |
|
1,304,128 |
|
|
|
1,286,674 |
|
Total liabilities, redeemable noncontrolling interests and equity |
$ |
4,669,842 |
|
|
$ |
4,591,842 |
|
Consolidated Statements of Cash Flows - Unaudited
|
Three Months Ended |
||||||
|
March 31, 2023 |
|
March 31, 2022 |
||||
|
|
|
|
||||
Operating Activities |
( |
||||||
Net income |
$ |
20,483 |
|
|
$ |
3,409 |
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities: |
|
|
|
||||
Depreciation and amortization |
|
32,291 |
|
|
|
31,013 |
|
Incremental charges on purchase accounting valuation of biological assets and inventory related to the acquisition of Legacy Dole |
|
— |
|
|
|
17,513 |
|
Net (gain) on sale of assets and asset write-offs |
|
(3,973 |
) |
|
|
(495 |
) |
Stock-based compensation expense |
|
1,330 |
|
|
|
648 |
|
Equity method earnings |
|
(1,478 |
) |
|
|
(577 |
) |
Amortization of debt discounts and debt issuance costs |
|
1,589 |
|
|
|
1,466 |
|
Deferred tax expense (benefit) |
|
7,370 |
|
|
|
(4,078 |
) |
Pension and other postretirement benefit plan expense (benefit) |
|
1,970 |
|
|
|
(1,023 |
) |
Dividends received from equity method investments |
|
— |
|
|
|
810 |
|
Other |
|
(3,083 |
) |
|
|
(69 |
) |
Changes in operating assets and liabilities: |
|
|
|
||||
Receivables, net of allowances |
|
(2,407 |
) |
|
|
(114,022 |
) |
Inventories |
|
(6,768 |
) |
|
|
(48,762 |
) |
Accrued and other current and long-term liabilities |
|
(32,097 |
) |
|
|
(31,124 |
) |
Net cash provided by (used in) operating activities |
|
15,227 |
|
|
|
(145,291 |
) |
Investing activities |
|
|
|
||||
Sales of assets |
|
6,529 |
|
|
|
15,620 |
|
Capital expenditures |
|
(19,891 |
) |
|
|
(17,330 |
) |
Acquisitions, net of cash acquired |
|
(1,405 |
) |
|
|
(1,399 |
) |
Insurance proceeds |
|
— |
|
|
|
776 |
|
Purchases of investments |
|
(790 |
) |
|
|
(412 |
) |
Sales (purchases) of unconsolidated affiliates |
|
1,507 |
|
|
|
(48 |
) |
Other |
|
17 |
|
|
|
3 |
|
Net cash (used in) investing activities |
|
(14,033 |
) |
|
|
(2,790 |
) |
Financing activities |
|
|
|
||||
Proceeds from borrowings and overdrafts |
|
392,054 |
|
|
|
341,795 |
|
Repayments on borrowings and overdrafts |
|
(347,448 |
) |
|
|
(212,414 |
) |
Dividends paid to shareholders |
|
(7,592 |
) |
|
|
(7,590 |
) |
Dividends paid to noncontrolling interests |
|
(1,918 |
) |
|
|
(3,616 |
) |
Other noncontrolling interest activity, net |
|
(476 |
) |
|
|
— |
|
Payment of contingent consideration |
|
(1,151 |
) |
|
|
(599 |
) |
Net cash provided by financing activities |
|
33,469 |
|
|
|
117,576 |
|
Effect of foreign exchange rate changes on cash |
|
2,697 |
|
|
|
(4,108 |
) |
Increase (decrease) in cash and cash equivalents |
|
37,360 |
|
|
|
(34,613 |
) |
Cash and cash equivalents at beginning of period |
|
228,840 |
|
|
|
250,561 |
|
Cash and cash equivalents at end of period |
$ |
266,200 |
|
|
$ |
215,948 |
|
Reconciliation from Net Income to Adjusted EBITDA - Unaudited
The following information is provided to give quantitative information related to items impacting comparability. Refer to the 'Non-GAAP Financial Measures' section of this document for additional detail on each item.
|
Three Months Ended |
||||||
|
March 31, 2023 |
|
March 31, 2022 |
||||
|
|
|
|
||||
|
( |
||||||
Net income (Reported GAAP) |
$ |
20,483 |
|
|
$ |
3,409 |
|
Loss from discontinued operations, net of income taxes |
|
14,506 |
|
|
|
25,230 |
|
Income from continuing operations (Reported GAAP) |
|
34,989 |
|
|
|
28,639 |
|
Income tax expense |
|
10,994 |
|
|
|
7,358 |
|
Interest expense |
|
21,712 |
|
|
|
11,616 |
|
Mark to market losses (gains) |
|
822 |
|
|
|
(1,138 |
) |
(Gain) on asset sales |
|
(4,167 |
) |
|
|
— |
|
Incremental charges on biological assets and inventory from the Acquisition |
|
— |
|
|
|
17,513 |
|
Cyber-related incident |
|
4,750 |
|
|
|
— |
|
Other items4 |
|
673 |
|
|
|
(868 |
) |
Adjustments from equity method investments |
|
1,323 |
|
|
|
1,128 |
|
Adjusted EBIT (Non-GAAP) |
|
71,096 |
|
|
|
64,248 |
|
Depreciation |
|
24,303 |
|
|
|
22,533 |
|
Amortization of intangible assets |
|
2,616 |
|
|
|
2,842 |
|
Depreciation and amortization adjustments from equity method investments |
|
2,372 |
|
|
|
2,260 |
|
Adjusted EBITDA (Non-GAAP) |
$ |
100,387 |
|
|
$ |
91,883 |
|
4 For the three months ended March 31, 2023, other items is comprised of |
Reconciliation from Net Income attributable to Dole plc shareholders to Adjusted Net Income - Unaudited
The following information is provided to give quantitative information related to items impacting comparability. Refer to the 'Non-GAAP Financial Measures' section of this document for additional detail on each item. Refer to the Appendix for supplementary detail.
|
Three Months Ended |
||||||
|
March 31, 2023 |
|
March 31, 2022 |
||||
|
|
|
|
||||
|
( |
||||||
Net income (loss) attributable to Dole plc (Reported GAAP) |
$ |
14,159 |
|
|
$ |
(1,394 |
) |
Loss from discontinued operations, net of income taxes |
|
14,506 |
|
|
|
25,230 |
|
Income from continuing operations attributable to Dole plc |
|
28,665 |
|
|
|
23,836 |
|
Adjustments: |
|
|
|
||||
Amortization of intangible assets |
|
2,616 |
|
|
|
2,842 |
|
Mark to market losses (gains) |
|
822 |
|
|
|
(1,138 |
) |
(Gain) on asset sales |
|
(4,167 |
) |
|
|
— |
|
Incremental charges on biological assets and inventory from the Acquisition |
|
— |
|
|
|
17,513 |
|
Cyber-related incident |
|
4,750 |
|
|
|
— |
|
Other items5 |
|
673 |
|
|
|
(868 |
) |
Adjustments from equity method investments |
|
119 |
|
|
|
678 |
|
Income tax on items above and discrete tax items |
|
(309 |
) |
|
|
(1,931 |
) |
NCI impact on items above |
|
(893 |
) |
|
|
(458 |
) |
Adjusted Net Income for Adjusted EPS calculation (Non-GAAP) |
$ |
32,276 |
|
|
$ |
40,474 |
|
|
|
|
|
||||
Adjusted earnings per share – basic (Non-GAAP) |
$ |
0.34 |
|
|
$ |
0.43 |
|
Adjusted earnings per share – diluted (Non-GAAP) |
$ |
0.34 |
|
|
$ |
0.43 |
|
Weighted average shares outstanding – basic |
|
94,899 |
|
|
|
94,878 |
|
Weighted average shares outstanding – diluted |
|
95,024 |
|
|
|
94,909 |
|
5 For the three months ended March 31, 2023, other items is comprised of |
Supplemental Reconciliation from Net Income attributable to Dole plc to Adjusted Net Income - Unaudited
The following information is provided to give quantitative information related to items impacting comparability. Refer to the 'Non-GAAP Financial Measures' section of this document for additional detail on each item.
|
Three Months Ended March 31, 2023
( |
||||||||||||||
|
Revenues, net |
Cost of sales |
Gross profit |
Gross Margin % |
Selling, marketing, general and administrative expenses |
Other operating charges6 |
Operating Income |
||||||||
Reported (GAAP) |
$ |
1,989,167 |
(1,810,128 |
) |
179,039 |
|
9.0 |
% |
(120,879 |
) |
3,973 |
|
$ |
62,133 |
|
Loss from discontinued operations, net of income taxes |
|
— |
— |
|
— |
|
|
— |
|
— |
|
|
— |
|
|
Amortization of intangible assets |
|
— |
— |
|
— |
|
2,616 |
|
— |
|
|
2,616 |
|
||
Mark to market losses (gains) |
|
— |
(1,390 |
) |
(1,390 |
) |
— |
|
— |
|
|
(1,390 |
) |
||
(Gain) on asset sales |
|
— |
— |
|
— |
|
— |
|
(4,167 |
) |
|
(4,167 |
) |
||
Cyber-related incident |
|
— |
— |
|
— |
|
4,750 |
|
— |
|
|
4,750 |
|
||
Other items |
|
— |
673 |
|
673 |
|
— |
|
— |
|
|
673 |
|
||
Adjustments from equity method investments |
|
— |
— |
|
— |
|
— |
|
— |
|
|
— |
|
||
Income tax on items above and discrete tax items |
|
— |
— |
|
— |
|
— |
|
— |
|
|
— |
|
||
NCI impact on items above |
|
— |
— |
|
— |
|
— |
|
— |
|
|
— |
|
||
Adjusted (Non-GAAP) |
$ |
1,989,167 |
(1,810,845 |
) |
178,322 |
|
9.0 |
% |
(113,513 |
) |
(194 |
) |
$ |
64,615 |
|
|
Three Months Ended March 31, 2022
( |
||||||||||||||
|
Revenues, net |
Cost of sales |
Gross profit |
Gross Margin % |
Selling, marketing, general and administrative expenses |
Other operating charges7 |
Operating Income (Loss) |
||||||||
Reported (GAAP) |
$ |
1,970,231 |
(1,818,436 |
) |
151,795 |
|
7.7 |
% |
(109,544 |
) |
737 |
|
$ |
42,988 |
|
Loss from discontinued operations, net of income taxes |
|
— |
— |
|
— |
|
|
— |
|
— |
|
|
— |
|
|
Amortization of intangible assets |
|
— |
— |
|
— |
|
|
2,842 |
|
— |
|
|
2,842 |
|
|
Mark to market losses (gains) |
|
— |
(4,088 |
) |
(4,088 |
) |
— |
|
— |
|
|
(4,088 |
) |
||
(Gain) on asset sales |
|
— |
— |
|
— |
|
— |
|
— |
|
|
— |
|
||
Incremental charges on biological assets and inventory from the Acquisition |
|
— |
17,513 |
|
17,513 |
|
— |
|
— |
|
|
17,513 |
|
||
Other items |
|
— |
(626 |
) |
(626 |
) |
— |
|
(242 |
) |
|
(868 |
) |
||
Adjustments from equity method investments |
|
— |
— |
|
— |
|
— |
|
— |
|
|
— |
|
||
Income tax on items above and discrete tax items |
|
— |
— |
|
— |
|
— |
|
— |
|
|
— |
|
||
NCI impact on items above |
|
— |
— |
|
— |
|
— |
|
— |
|
|
— |
|
||
Adjusted (Non-GAAP) |
$ |
1,970,231 |
(1,805,637 |
) |
164,594 |
|
8.4 |
% |
(106,702 |
) |
495 |
|
$ |
58,387 |
|
6 Other operating charges for the three months ended March 31, 2023 is comprised of gains on asset sales of |
7 Other operating charges for the three months ended March 31, 2022 is comprised of gains from disposal of businesses of |
Three Months Ended March 31, 2023
( |
||||||||||||||
|
Other income, net |
Interest
|
Interest expense |
Income tax expense |
Equity method earnings |
Income from continuing operations |
Loss from discontinued operations, net of income taxes |
|||||||
Reported (GAAP) |
$ |
1,775 |
2,309 |
(21,712 |
) |
(10,994 |
) |
1,478 |
|
34,989 |
|
$ |
(14,506 |
) |
Loss from discontinued operations, net of income taxes |
|
— |
— |
— |
|
— |
|
— |
|
— |
|
|
14,506 |
|
Amortization of intangible assets |
|
— |
— |
— |
|
— |
|
— |
|
2,616 |
|
|
— |
|
Mark to market losses (gains) |
|
2,212 |
— |
— |
|
— |
|
— |
|
822 |
|
|
— |
|
(Gain) on asset sales |
|
— |
— |
— |
|
— |
|
— |
|
(4,167 |
) |
|
— |
|
Cyber-related incident |
|
— |
— |
— |
|
— |
|
— |
|
4,750 |
|
|
— |
|
Other items |
|
— |
— |
— |
|
— |
|
— |
|
673 |
|
|
— |
|
Adjustments from equity method investments |
|
— |
— |
— |
|
— |
|
119 |
|
119 |
|
|
— |
|
Income tax on items above and discrete tax items |
|
— |
— |
— |
|
(228 |
) |
(81 |
) |
(309 |
) |
|
— |
|
NCI impact on items above |
|
— |
— |
— |
|
— |
|
— |
|
— |
|
|
— |
|
Adjusted (Non-GAAP) |
$ |
3,987 |
2,309 |
(21,712 |
) |
(11,222 |
) |
1,516 |
|
39,493 |
|
$ |
— |
|
|
Three Months Ended March 31, 2022
( |
|||||||||||||
|
Other income, net |
Interest
|
Interest expense |
Income tax expense |
Equity method earnings |
Income from continuing operations |
Loss from discontinued operations, net of income taxes |
|||||||
Reported (GAAP) |
$ |
2,464 |
1,584 |
(11,616 |
) |
(7,358 |
) |
577 |
|
28,639 |
|
$ |
(25,230 |
) |
Loss from discontinued operations, net of income taxes |
|
— |
— |
— |
|
— |
|
— |
|
— |
|
|
25,230 |
|
Amortization of intangible assets |
|
— |
— |
— |
|
— |
|
— |
|
2,842 |
|
|
— |
|
Mark to market losses (gains) |
|
2,950 |
— |
— |
|
— |
|
— |
|
(1,138 |
) |
|
— |
|
(Gain) on asset sales |
|
— |
— |
— |
|
— |
|
— |
|
— |
|
|
— |
|
Incremental charges on biological assets and inventory from the Acquisition |
|
— |
— |
— |
|
— |
|
— |
|
17,513 |
|
|
— |
|
Other items |
|
— |
— |
— |
|
— |
|
— |
|
(868 |
) |
|
— |
|
Adjustments from equity method investments |
|
— |
— |
— |
|
— |
|
678 |
|
678 |
|
|
— |
|
Income tax on items above and discrete tax items |
|
— |
— |
— |
|
(1,828 |
) |
(103 |
) |
(1,931 |
) |
|
— |
|
NCI impact on items above |
|
— |
— |
— |
|
— |
|
— |
|
— |
|
|
— |
|
Adjusted (Non-GAAP) |
$ |
5,414 |
1,584 |
(11,616 |
) |
(9,186 |
) |
1,152 |
|
45,735 |
|
$ |
— |
|
|
Three Months Ended March 31, 2023 |
||||||||||
|
( |
||||||||||
|
Net income |
Net income
|
Net income (loss)
|
Diluted net
|
|||||||
Reported (GAAP) |
$ |
20,483 |
|
$ |
(6,324 |
) |
$ |
14,159 |
|
$ |
0.15 |
Loss from discontinued operations, net of income taxes |
|
14,506 |
|
|
— |
|
|
14,506 |
|
|
|
Amortization of intangible assets |
|
2,616 |
|
|
— |
|
|
2,616 |
|
||
Mark to market losses (gains) |
|
822 |
|
|
— |
|
|
822 |
|
||
(Gain) on asset sales |
|
(4,167 |
) |
|
— |
|
|
(4,167 |
) |
||
Cyber-related incident |
|
4,750 |
|
|
— |
|
|
4,750 |
|
||
Other items |
|
673 |
|
|
— |
|
|
673 |
|
||
Adjustments from equity method investments |
|
119 |
|
|
— |
|
|
119 |
|
||
Income tax on items above and discrete tax items |
|
(309 |
) |
|
— |
|
|
(309 |
) |
||
NCI impact on items above |
|
— |
|
|
(893 |
) |
|
(893 |
) |
||
Adjusted (Non-GAAP) |
$ |
39,493 |
|
$ |
(7,217 |
) |
$ |
32,276 |
|
$ |
0.34 |
|
|
|
|
|
|||||||
Weighted average shares outstanding – diluted |
|
95,024 |
|
|
|
|
|
Three Months Ended March 31, 2022 |
|||||||||||
|
( |
|||||||||||
|
Net income |
Net income
|
Net income (loss)
|
Diluted net
|
||||||||
Reported (GAAP) |
$ |
3,409 |
|
$ |
(4,803 |
) |
$ |
(1,394 |
) |
$ |
(0.01 |
) |
Loss from discontinued operations, net of income taxes |
|
25,230 |
|
|
— |
|
|
25,230 |
|
|
||
Amortization of intangible assets |
|
2,842 |
|
|
— |
|
|
2,842 |
|
|||
Mark to market losses (gains) |
|
(1,138 |
) |
|
— |
|
|
(1,138 |
) |
|||
(Gain) on asset sales |
|
— |
|
|
— |
|
|
— |
|
|||
Incremental charges on biological assets and inventory from the Acquisition |
|
17,513 |
|
|
— |
|
|
17,513 |
|
|||
Other items |
|
(868 |
) |
|
— |
|
|
(868 |
) |
|||
Adjustments from equity method investments |
|
678 |
|
|
— |
|
|
678 |
|
|||
Income tax on items above and discrete tax items |
|
(1,931 |
) |
|
— |
|
|
(1,931 |
) |
|||
NCI impact on items above |
|
— |
|
|
(458 |
) |
|
(458 |
) |
|||
Adjusted (Non-GAAP) |
$ |
45,735 |
|
$ |
(5,261 |
) |
$ |
40,474 |
|
$ |
0.43 |
|
|
|
|
|
|
||||||||
Weighted average shares outstanding – diluted |
|
94,909 |
|
|
|
|
Supplemental Reconciliation of Prior Year Segment Results to Current Year Segment Results – Unaudited
|
Revenue for the Three Months Ended |
|||||||||||||||||
|
March 31,
|
|
Impact of
|
|
Impact of
|
|
Like-for-like
|
|
March 31,
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||
|
( |
|||||||||||||||||
Fresh Fruit |
$ |
749,803 |
|
|
$ |
— |
|
|
$ |
— |
|
$ |
49,107 |
|
|
$ |
798,910 |
|
Diversified Fresh Produce - EMEA |
|
791,155 |
|
|
|
(53,360 |
) |
|
|
2,252 |
|
|
58,053 |
|
|
|
798,100 |
|
Diversified Fresh Produce - |
|
463,692 |
|
|
|
(2,786 |
) |
|
|
— |
|
|
(38,155 |
) |
|
|
422,751 |
|
Intersegment |
|
(34,419 |
) |
|
|
— |
|
|
|
— |
|
|
3,825 |
|
|
|
(30,594 |
) |
Total |
$ |
1,970,231 |
|
|
$ |
(56,146 |
) |
|
$ |
2,252 |
|
$ |
72,830 |
|
|
$ |
1,989,167 |
|
|
Adjusted EBITDA for the Three Months Ended |
||||||||||||||||||
|
March 31, 2022 |
|
Impact of
|
|
Impact of
|
|
Like-for-like
|
|
March 31,
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||
|
( |
||||||||||||||||||
Fresh Fruit |
$ |
60,397 |
|
$ |
145 |
|
|
$ |
— |
|
$ |
8,669 |
|
|
$ |
69,211 |
|||
Diversified Fresh Produce - EMEA |
|
19,277 |
|
|
(1,628 |
) |
|
|
758 |
|
|
4,999 |
|
|
|
23,406 |
|||
Diversified Fresh Produce - |
|
12,209 |
|
|
(31 |
) |
|
|
128 |
|
|
(4,536 |
) |
|
|
7,770 |
|||
Total |
$ |
91,883 |
$ |
(1,514 |
) |
$ |
886 |
$ |
9,132 |
|
|
$ |
100,387 |
||||||
|
|
|
|
|
|
|
|
|
|
Net Debt Reconciliation
Net Debt is the primary measure used by management to analyze the Company’s capital structure. Net Debt is a non-GAAP financial measure, calculated as cash and cash equivalents, less current and long-term debt. It also excludes debt discounts and debt issuance costs. The calculation of Net Debt as of March 31, 2023 is presented below. Net Debt as of March 31, 2023 was
|
March 31,
|
|
December 31,
|
||||
|
( |
||||||
Cash and cash equivalents (Reported GAAP) |
$ |
266,200 |
|
|
$ |
228,840 |
|
Debt (Reported GAAP): |
|
|
|
||||
Long-term debt, net |
|
(1,013,984 |
) |
|
|
(1,127,321 |
) |
Current maturities |
|
(255,052 |
) |
|
|
(97,435 |
) |
Bank overdrafts |
|
(11,898 |
) |
|
|
(8,623 |
) |
Total debt, net |
|
(1,280,934 |
) |
|
|
(1,233,379 |
) |
Less: Debt discounts and debt issuance costs (Reported GAAP) |
|
(17,000 |
) |
|
|
(17,874 |
) |
Total gross debt |
|
(1,297,934 |
) |
|
|
(1,251,253 |
) |
Net Debt (Non-GAAP) |
$ |
(1,031,734 |
) |
|
$ |
(1,022,413 |
) |
Non-GAAP Financial Measures
Dole plc’s results are determined in accordance with
In addition to its results under
Adjusted EBIT is calculated from GAAP net income by: (1) adding the loss from discontinued operations, net of income taxes, or subtracting the income from discontinued operations, net of income taxes; (2) adding the income tax expense or subtracting the income tax benefit; (3) adding interest expense; (4) adding mark to market losses or subtracting mark to market gains related to unrealized impacts from derivative instruments and foreign currency denominated borrowings, realized impacts on noncash settled foreign currency denominated borrowings, net foreign currency impacts on liquidated entities and fair value movements on contingent consideration; (5) other items which are separately stated based on materiality, which include adding merger, transaction and other related costs, adding incremental costs for produce recalls, adding or subtracting asset write-downs, net of insurance proceeds, subtracting the gain or adding the loss on the disposal of business interests, adding the incremental costs from the fair value uplift for biological assets and inventory related to the acquisition of Legacy Dole, adding impairment charges on property, plant and equipment, subtracting the fair value gain or adding the fair value loss on the acquisition of investments previously accounted for under the equity method, subtracting the gain or adding the loss on the sale of investments accounted for under the equity method, subtracting the gain or adding the loss on asset sales for assets held-for-sale and actively marketed property and adding restructuring charges, costs for legal matters not in the ordinary course of business and costs incurred for cyber-related incidents; and (6) other adjustments from equity method investments, which includes the Company’s share of these items within equity method earnings.
Adjusted EBITDA is calculated from GAAP net income by: (1) adding the loss from discontinued operations, net of income taxes, or subtracting the income from discontinued operations, net of income taxes; (2) adding the income tax expense or subtracting the income tax benefit; (3) adding interest expense; (4) adding depreciation charges; (5) adding amortization charges; (6) adding mark to market losses or subtracting mark to market gains related to unrealized impacts from derivative instruments and foreign currency denominated borrowings, realized impacts on noncash settled foreign currency denominated borrowings, net foreign currency impacts on liquidated entities and fair value movements on contingent consideration; (7) other items which are separately stated based on materiality, which include adding merger, transaction and other related costs, adding incremental costs for produce recalls, adding or subtracting asset write-downs, net of insurance proceeds, subtracting the gain or adding the loss on the disposal of business interests, adding the incremental costs from the fair value uplift for biological assets and inventory related to the acquisition of Legacy Dole, adding impairment charges on property, plant and equipment, subtracting the fair value gain or adding the fair value loss on the acquisition of investments previously accounted for under the equity method, subtracting the gain or adding the loss on the sale of investments accounted for under the equity method, subtracting the gain or adding the loss on asset sales for assets held-for-sale and actively marketed property and adding restructuring charges, costs for legal matters not in the ordinary course of business and costs incurred for cyber-related incidents; and (8) other adjustments from equity method investments, which includes the Company’s share of these items within equity method earnings.
Adjusted Net Income is calculated from GAAP net income attributable to Dole plc by: (1) adding the loss from discontinued operations, net of income taxes, or subtracting the income from discontinued operations, net of income taxes (2) adding amortization charges; (3) adding mark to market losses or subtracting mark to market gains related to unrealized impacts from derivative instruments and foreign currency denominated borrowings, realized impacts on noncash settled foreign currency denominated borrowings, net foreign currency impacts on liquidated entities and fair value movements on contingent consideration; (4) other items which are separately stated based on materiality, which include adding merger, transaction and other related costs, adding incremental costs for produce recalls, adding or subtracting asset write-downs, net of insurance proceeds, subtracting the gain or adding the loss on the disposal of business interests, adding the incremental costs from the fair value uplift for biological assets and inventory related to the acquisition of Legacy Dole, adding impairment charges on property, plant and equipment, subtracting the fair value gain or adding the fair value loss on the acquisition of investments previously accounted for under the equity method, subtracting the gain or adding the loss on the sale of investments accounted for under the equity method, subtracting the gain or adding the loss on asset sales for assets held-for-sale and actively marketed property and adding restructuring charges, costs for legal matters not in the ordinary course of business and costs incurred for cyber-related incidents; (5) other adjustments from equity method investments, which includes the Company’s share of these items within equity method earnings; (6) excluding the tax effect of these items and discrete tax adjustments; and (7) excluding the effect of these items attributable to non-controlling interests.
Adjusted Earnings per Share is calculated from Adjusted Net Income divided by diluted weighted average number of shares in the applicable period.
Net Debt is a non-GAAP financial measure, calculated as GAAP cash and cash equivalents, less GAAP current and long-term debt. It also excludes GAAP debt discounts and debt issuance costs.
Dole is not able to provide a reconciliation for projected FY'23 results without taking unreasonable efforts.
Category: Financial
View source version on businesswire.com: https://www.businesswire.com/news/home/20230518005084/en/
Investor Contact:
James O'Regan, Head of Investor Relations, Dole plc
joregan@totalproduce.com
+353 1 887 2794
Media Contact:
Brian Bell, Ogilvy
brian.bell@ogilvy.com
+353 87 2436 130
Source: Dole plc